COMPARATIVE ASSESSMENT OF THE TURNOVER OF ANTIMICROBIAL VETERINARY MEDICINAL PRODUCTS IN UKRAINE AND EU MEMBER STATES

Y. Kosenko, N. Ostapiv, L. Zaruma
{"title":"COMPARATIVE ASSESSMENT OF THE TURNOVER OF ANTIMICROBIAL VETERINARY MEDICINAL PRODUCTS IN UKRAINE AND EU MEMBER STATES","authors":"Y. Kosenko, N. Ostapiv, L. Zaruma","doi":"10.36359/scivp.2023-24-1.08","DOIUrl":null,"url":null,"abstract":"Governments of many countries and professional organizations, including Ukraine, have developed a lot of legislative and regulatory documents and recommendations to tackle the development of acquired antimicrobial resistance, based on the of “One Health” concept. Monitoring the manifestation of acquired antimicrobial resistance and the circulation of antimicrobial veterinary medicinal products is one of the keys to solving this problem. \nThe main goal of this study was to determine the trends in the sales volumes of antimicrobial veterinary medicinal products and compare them with the turnover of such products in the EU/EEA member states during 2021. \nSince 2015, the World Organization for Animal Health (WOAH) has taken the lead to build a global interactive automated database on antimicrobial agents ANIMUSE to facilitate countries' reporting, analysis, and interpretation of data. In 2022, Ukraine, like other countries, for the first time submitted an annual sales volumes report of antimicrobial veterinary medicinal products online to the global ANIMUSE database on the antimicrobials intended for use in animals (AMU). \nAs a result of the sales volumes reports of antimicrobial veterinary medicinal products analysis for 2021, common trends were revealed in Ukraine and EU/EEA member states regarding the circulation of antimicrobial veterinary medicinal products of category D, in particular tetracyclines and penicillins. However, was established an increase in the sales share of aminoglycosides (7.93 %), polymyxins (8.5 %) and fluoroquinolones (10.4 %), and the 3rd and 4th generation cephalosporins (0.72 %) in Ukraine, which are classified as categories C and B, the use of which must be reasonable in the absence of alternatives from category D. \nMonitoring data of sales volumes does not allow us to assert that all of the sold antimicrobials were used during the reporting period, however, the increase in their share in sales volumes is worrisome following the requirements stated by the “Procedure for the use of antimicrobial veterinary medicinal products”, approved by order of the Ministry of Economy of Ukraine No. 1177-21 of 12.30.2021.","PeriodicalId":21617,"journal":{"name":"Scientific and Technical Bulletin оf State Scientific Research Control Institute of Veterinary Medical Products and Fodder Additives аnd Institute of Animal Biology","volume":"78 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Scientific and Technical Bulletin оf State Scientific Research Control Institute of Veterinary Medical Products and Fodder Additives аnd Institute of Animal Biology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36359/scivp.2023-24-1.08","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Governments of many countries and professional organizations, including Ukraine, have developed a lot of legislative and regulatory documents and recommendations to tackle the development of acquired antimicrobial resistance, based on the of “One Health” concept. Monitoring the manifestation of acquired antimicrobial resistance and the circulation of antimicrobial veterinary medicinal products is one of the keys to solving this problem. The main goal of this study was to determine the trends in the sales volumes of antimicrobial veterinary medicinal products and compare them with the turnover of such products in the EU/EEA member states during 2021. Since 2015, the World Organization for Animal Health (WOAH) has taken the lead to build a global interactive automated database on antimicrobial agents ANIMUSE to facilitate countries' reporting, analysis, and interpretation of data. In 2022, Ukraine, like other countries, for the first time submitted an annual sales volumes report of antimicrobial veterinary medicinal products online to the global ANIMUSE database on the antimicrobials intended for use in animals (AMU). As a result of the sales volumes reports of antimicrobial veterinary medicinal products analysis for 2021, common trends were revealed in Ukraine and EU/EEA member states regarding the circulation of antimicrobial veterinary medicinal products of category D, in particular tetracyclines and penicillins. However, was established an increase in the sales share of aminoglycosides (7.93 %), polymyxins (8.5 %) and fluoroquinolones (10.4 %), and the 3rd and 4th generation cephalosporins (0.72 %) in Ukraine, which are classified as categories C and B, the use of which must be reasonable in the absence of alternatives from category D. Monitoring data of sales volumes does not allow us to assert that all of the sold antimicrobials were used during the reporting period, however, the increase in their share in sales volumes is worrisome following the requirements stated by the “Procedure for the use of antimicrobial veterinary medicinal products”, approved by order of the Ministry of Economy of Ukraine No. 1177-21 of 12.30.2021.
乌克兰和欧盟成员国抗菌兽药产品营业额的比较评估
包括乌克兰在内的许多国家政府和专业组织根据"同一个健康"概念制定了许多立法和监管文件和建议,以解决获得性抗微生物药物耐药性的问题。监测获得性耐药的表现和抗菌兽药的流通是解决这一问题的关键之一。本研究的主要目标是确定抗菌兽药产品的销量趋势,并将其与2021年欧盟/欧洲经济区成员国此类产品的营业额进行比较。自2015年以来,世界动物卫生组织(WOAH)率先建立了一个关于抗菌药物ANIMUSE的全球交互式自动化数据库,以促进各国报告、分析和解释数据。2022年,乌克兰与其他国家一样,首次在线向动物用抗菌剂全球ANIMUSE数据库(AMU)提交了抗微生物兽药产品年度销量报告。根据2021年抗菌兽药产品销售量分析报告,揭示了乌克兰和欧盟/欧洲经济区成员国关于D类抗菌兽药产品流通的共同趋势,特别是四环素和青霉素类。然而,成立的销售份额的增加氨基甙类抗生素(7.93%)、多粘菌素(8.5%)和氟喹诺酮类原料药(10.4%),第三和第四代头孢菌素(0.72%)在乌克兰,被归类为类别C和B,必须合理的使用类别d .监控数据的缺乏替代品销量不允许我们断言,所有的使用抗菌素报告期销售,然而,根据乌克兰经济部2021年12月30日第1177-21号命令批准的“抗菌兽药产品使用程序”规定的要求,其销售额份额的增加令人担忧。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信